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LEITERS TO THE EDITOR 
Reactivity of Sera from Bullous Pemphigoid Patients on Blotted Epidermal 
Extracts 
T o the Editor: 
W e read with great interest the recent paper by Bernard ct 31 \1} 
describing the reactiviry of sera from bullous pemph igoid (BP) pa-
tients on blotted epidermal cxtraC[s. Their results were consisten t 
with a molecular heterogeneity of BP antigen (\5 previously reponed 
by ubib et al [2]. The authors also focussed their interest on BF sera 
Jacking anti-basement membrane 'Zone (BMZ) antibodies demon-
strable by indi.rect immu.no£luoresccnce (llF). They concluded that 
western immunoblocting might be a more sensi ti ve method for the 
detection of BP autoantibodies thall lIF techniques. We had re-
ported similar conclusi.ons in a paper published as soon as January 
1988 /.3 J, which was surprisingly not refe renced by the authors, 
possibly because they did not take imo comide-ration data published 
in French journals. Fortunately we have e)C.tended this work in 
AUloimmu"icy [4J. These reports uuderlined that some BP sera did 
not react in UF assay as well as in immunoblorting experiments, 
al though in vivo-bound imrnunoreactants were found alon.g the 
BMZ. which dearly represents a puzzling point. The absence of 
circulating free anti-DMZ an ti bodies in BP patients has been corre-
lated with high levels of circulating immune complexes [5]. It is 
possible that BMZ antigens released from damaged tissue combine 
with free antibod ies ~nd form complexes in the blood srream. Ac-
cording to this view. we can speculate that in some active stages of 
the disease. antibod ies could be fully trapped in immune complexes, 
thus being unavailable fo r any other reaction wi th antigenic targeu. 
It would he of importance to ciucid;1tc this point in otder to better 
understand thc physiopathology of bullous pemphigoid. 
A . R cano, ph,D. 
J. Thivolet, M.D. 
Lyon. France 
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REPLY 
W e do agree that they nrst suggested that western immunoblotting 
might be a morc sensirive merhod for the de tection of bullous pem-
phigoid (BP) autoantibodies than the indirect immunofluorescence 
(11F) technique lll. H owever, rheir paper a~eeared after our manu-
script was first submicced for publication [2j, because rh(' J :muary 
issue of rhe A,males de Dermatologie is di ligently delivered around 
April CO French d('rmacologis[s. In any case, we take this as a good 
opportunity to call a special attention to the French literature. 
We do nor think th :u Reano et al have compared the respective 
sensitivity of weste.rn immunoblorring and IIF because 1. The small 
number of tested BP patients (9 IIF positive and 9 IlF negative) 
didn't allow a valid statistical analysis. 2. The substrates used for UF 
(prepuce skin) and westemblot (suspension of keratinocytes from 
abdominal dcrmohpcctomy) studies were not identicaL 3. The 
se ronegarivity by IIF was neither entirely defined (minimal tested 
diJution?) nor extensively studied (absence of anti-C3 lIF or IIF on 
1.0 M N.CI split skin). 
Finally, we think thar al though wesremblor studiesofBP patients 
do underline the complexiry of the autoimmune response in dlis 
disease in terms of epitope [3, 4), it is dear that the exact biochemical 
definition of BP antigen is dependent on the current advances of 
molecular biology [5.6.7]' When this will be clearly established. a 
better ddi.nitlon of the seropositivity of BP patienu may be ex -
pected. using, for example, the E.L.I .s.A. technique. 
P. Bernard, M.D. 
J.M. Bonnecblanc, M.D. 
J.H. Saurat, M.D. 
Service de Dermatologie (PB. JMB), 
C. H .U. Dupuytren Limoges France Clinique de Dermatologie 
(JHS). 
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